Unique ID issued by UMIN | UMIN000041086 |
---|---|
Receipt number | R000046919 |
Scientific Title | Immune checkpoint inhibitors versus ramucirumab plus docetaxel for refractory or relapsed advanced non-small cell lung cancer: A systematic review and network meta-analysis of phase 3 randomized clinical trials. |
Date of disclosure of the study information | 2020/07/20 |
Last modified on | 2020/08/31 12:20:11 |
Immune checkpoint inhibitors versus ramucirumab plus docetaxel for refractory or relapsed advanced non-small cell lung cancer: A systematic review and network meta-analysis of phase 3 randomized clinical trials.
Immune checkpoint inhibitors versus ramucirumab plusdocetaxel for refractory or relapsed advanced NSCLC
Immune checkpoint inhibitors versus ramucirumab plus docetaxel for refractory or relapsed advanced non-small cell lung cancer: A systematic review and network meta-analysis of phase 3 randomized clinical trials.
Immune checkpoint inhibitors versus ramucirumab plusdocetaxel for refractory or relapsed advanced NSCLC
Japan |
Non-small cell lung cancer
Pneumology |
Malignancy
NO
To compare the efficacy and safety for refractory of relapsedadvanced non-small cell lung cancer among Ramucirumab plus Docetaxel, nivolumab, atezolizumab, and Docetaxel.
Safety,Efficacy
Overall survival and Grade 3-5 adverse events
progression free survival
Others,meta-analysis etc
18 | years-old | <= |
Not applicable |
Male and Female
refractory or relapsed advanced non-small lung cancer
performance status of 0 or 1
(The article search were restricted to those published in the English language)
500
1st name | Koichi |
Middle name | |
Last name | Ando |
Showa University school of medicine
Department of Medicine, Division of Respiratory Medicine and Allergology,
142-8666
1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan
+81-3-3784-8532
koichi-a@med.showa-u.ac.jp
1st name | Koichi |
Middle name | |
Last name | Ando |
Ando
Department of Medicine, Division of Respiratory Medicine and Allergology,
142-8666
1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan
+81-3-3784-8532
koichi-a@med.showa-u.ac.jp
Showa University
Showa University
Other
Showa University School of Medicine
1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan
+81-3-3784-8532
koichi-a@med.showa-u.ac.jp
NO
2020 | Year | 07 | Month | 20 | Day |
Unpublished
1526
Completed
2020 | Year | 07 | Month | 13 | Day |
2020 | Year | 07 | Month | 13 | Day |
2020 | Year | 07 | Month | 13 | Day |
2020 | Year | 08 | Month | 31 | Day |
This analysis adopted the Bayesian model. To estimate the posterior distribution of treatment effects, this Bayesian analysis involve the adaptation of a non-informative prior distribution and Gibbs sampling using the Markov chain Monte Carlo method.
2020 | Year | 07 | Month | 13 | Day |
2020 | Year | 08 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046919
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |